✉news HealthPandemics first seen 1 d ago, last 14 h ago, peak #15
Regeneron lands $270 million US Ebola order as African outbreak nears 10,000 cases
Original: New York-listed Regeneron secures $270 million US Ebola order as African outbreak approaches 10,000 infections
Regeneron, the New York-listed biotech firm, has secured a $270 million order from the US government for its Ebola treatment as an outbreak in Africa approaches 10,000 infections. The deal signals growing international concern that the epidemic could spread beyond the region, prompting governments to stock up on therapies. Commentators are watching how the outbreak develops and whether the purchase accelerates wider preparedness efforts.
Why now: The escalating Ebola outbreak in Africa and fears of wider spread are driving attention to treatment procurement.
RegeneronUnited States governmentAfrica
Evidence
- New York-listed Regeneron secures $270 million US Ebola order as African outbreak approaches 10,000 infections · Business Insider Africa
API: https://socialmediatrends-api.osmike.com/v1/trends/3973323